Purdue won approval of a chapter 11 reorganization plan that will end civil lawsuits against the Sacklers and turn the OxyContin maker into a public benefit company addressing the opioid crisis. Here are details about the settlement plan and how it works.
of a multibillion restructuring plan that will turn the drugmaker into a new public benefit company that will use its resources to address the opioid epidemic and compensate people and families harmed by its products.
The restructuring includes roughly $4.5 billion in settlement payments from members of the Sackler family who own the company. Here are details about the settlement plan and how it works.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Purdue Pharma Bankruptcy Plan Approved, Freeing Sacklers From LawsuitsThe OxyContin maker won court approval of a roughly $4.5 billion bankruptcy settlement that shields its owners, members of the Sackler family, from lawsuits accusing them of contributing to the opioid epidemic in exchange for providing funds to combat the crisis.
Read more »
Judge begins ruling on Purdue Pharma bankruptcy plan that shields SacklersA U.S. judge began delivering his ruling on Wednesday on OxyContin maker Purdue Pharma's request to approve its bankruptcy reorganization plan that would shield the company's Sackler family owners from future litigation over the opioid crisis.
Read more »
Judge will approve Purdue Pharma bankruptcy that shields Sacklers from opioid lawsuitsNEW: A U.S. judge says he would approve OxyContin maker Purdue Pharma LP’s bankruptcy reorganization plan, clearing a path to resolve thousands of opioid lawsuits and shielding the Sackler family from future opioid litigation.
Read more »
Judge Set To Rule On Purdue Pharma's Opioid Settlement PlanA U.S. bankruptcy judge is expected to rule on whether the OxyContin maker will settle thousands of lawsuits.
Read more »
Judge conditionally approves Purdue Pharma opioid settlementUnder the settlement, the Sackler family will give up company ownership and contribute $4.5 billion and will be shielded from any future opioid lawsuits.
Read more »
Judge Tentatively OKs Purdue Pharma Deal In Opioid CasesThe Sackler family will give up ownership of the company and contribute $4.5 billion but will be freed from any future lawsuits over opioids.
Read more »